APP and Alzheimer disease: Altogether, given the cognitive deficits observed in APP/PS1 mice [58], the pre- and post-synaptic reduction in GABAB receptors in granule cells, together with the alterations affecting other principal cells of the hippocampus [17], may represent the molecular and anatomical substrate of the altered cognitive function observed in this mouse model of AD.